Family History of Bowel Cancer?, Information for Health Professionals

NCHPEG & AMA Release New Educational Program on Hereditary CRC

NCHPEG & AMA Release New Program on Hereditary CRC

NCHPEG and the American Medical Association (AMA) have released a free Web-based educational program designed to improve the primary care provider’s ability to identify hereditary colorectal cancer syndromes in their patients. This program focuses on case-based learning through a series of clinical scenarios that apply point-of-care tools to key clinical roles in risk assessment, genetic testing, communication, and management. The program also provides access to the point-of-care tools as downloadable pdfs for use in patient care.

alt“With rapidly developing advances in genetic and molecular medicine, physicians are seeking ways to stay up-to-date in this field to better serve their patients,” said AMA President Jeremy A. Lazarus, M.D. “These developments have made it possible for physicians to now identify hereditary cancer syndromes by looking for specific clues in a patient’s personal and family medical history. We created this educational program to help physicians identify, evaluate, communicate with and manage patients at increased risk for colorectal cancer.”

Colorectal cancer affects approximately 140,000 individuals annually in the U.S. Like other cancers, it develops due to a combination of genetic, biologic and environmental factors interacting together. Approximately 5-10 percent of colorectal cancers are caused by a hereditary syndrome in which a single gene alteration conveys a high risk of colorectal and sometimes other cancers. Individuals suspected to have a hereditary cancer syndrome can sometimes be offered genetic testing to aid in the diagnosis.

“Physicians and other health providers often need information and tools to integrate genetics into their practice,” said NCHPEG Executive Director Joan Scott, M.S., C.G.C. “We developed this program to allow providers to learn as they apply skills through working through cases.  They leave the program with knowledge, skills and easily accessible point-of-care tools they can use with their patients.”

This course is available freely available to all users.  CME is available in both an enduring, traditional format and a performance improvement format.  The enduring format of the course has been certified for 6.0 AMA PRA Category 1 CreditsTM, while participants who complete all three stages of the performance improvement format are eligible for 20.0 AMA PRA Category 1 CreditsTM.

This program was funded by Myriad Genetics, VHA Contract #VA200P0034, AMA, and Humana.

Interested in taking the program? The course is available in both an enduring format and a performance improvement format for CME credit. Individuals who do not plan to apply for CME should register for the enduring course. Click on the links to read more about each option and register.

Interested in learning more? Read the Introduction to the program, which includes the learning objectives and other information, and see the press release.


About kjmonahan

Service lead for Family History of Bowel Cancer Clinic



  1. Pingback: Fibroids Hereditary - December 21, 2012

  2. Pingback: Are Uterine Fibroids Hereditary - February 1, 2013

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 1,483 other followers

RSS CRUK Bowel Cancer Blog

  • An error has occurred; the feed is probably down. Try again later.

RSS Pubmed New Publications

RSS Familial Cancer

  • An error has occurred; the feed is probably down. Try again later.


Google Plus

%d bloggers like this: